DE69924615D1 - Thymosin beta 4 stimuliert wundheilung - Google Patents
Thymosin beta 4 stimuliert wundheilungInfo
- Publication number
- DE69924615D1 DE69924615D1 DE69924615T DE69924615T DE69924615D1 DE 69924615 D1 DE69924615 D1 DE 69924615D1 DE 69924615 T DE69924615 T DE 69924615T DE 69924615 T DE69924615 T DE 69924615T DE 69924615 D1 DE69924615 D1 DE 69924615D1
- Authority
- DE
- Germany
- Prior art keywords
- wound healing
- stimulated wound
- thymosine beta
- thymosine
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/18—Thymus derived hormone or factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Urology & Nephrology (AREA)
- Silicon Polymers (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9469098P | 1998-07-30 | 1998-07-30 | |
US94690P | 1998-07-30 | ||
PCT/US1999/017282 WO2000006190A1 (en) | 1998-07-30 | 1999-07-29 | THYMOSIN β4 PROMOTES WOUND REPAIR |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69924615D1 true DE69924615D1 (de) | 2005-05-12 |
DE69924615T2 DE69924615T2 (de) | 2006-02-02 |
DE69924615T3 DE69924615T3 (de) | 2011-05-05 |
Family
ID=22246605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69924615T Expired - Lifetime DE69924615T3 (de) | 1998-07-30 | 1999-07-29 | Thymosin beta 4 stimuliert wundheilung |
Country Status (12)
Country | Link |
---|---|
US (6) | US20070111931A9 (de) |
EP (3) | EP2311485A1 (de) |
AT (1) | ATE292473T1 (de) |
AU (1) | AU766826B2 (de) |
CA (1) | CA2338928A1 (de) |
DE (1) | DE69924615T3 (de) |
DK (1) | DK1100529T4 (de) |
ES (1) | ES2239846T5 (de) |
HK (1) | HK1038307A1 (de) |
MX (1) | MXPA01001041A (de) |
PT (1) | PT1100529E (de) |
WO (1) | WO2000006190A1 (de) |
Families Citing this family (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070191275A1 (en) * | 1998-07-30 | 2007-08-16 | Regenerx Biopharmaceuticals, Inc. | Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments |
US20070015698A1 (en) * | 1998-07-30 | 2007-01-18 | United States Of America As Represented By The Secretary Of Health | Treatment of skin, and wound repair, with thymosin beta 4 |
US20080096817A1 (en) * | 1998-07-30 | 2008-04-24 | Regenerx Biopharmaceuticals, Inc. | METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES |
US20040170625A1 (en) * | 1998-07-30 | 2004-09-02 | Regenerx Biopharmaceuticals, Inc. | Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives |
WO2002091969A1 (en) * | 2001-05-17 | 2002-11-21 | Regenerx Biopharmaceuticals, Inc. | Treating epidermlyosis bullosa with thymosin beta 4 |
CA2338928A1 (en) * | 1998-07-30 | 2000-02-10 | Hynda K. Kleinman | Thymosin .beta.4 promotes wound repair |
WO2002036143A1 (en) | 2000-11-02 | 2002-05-10 | Regenerx Biopharmaceuticals, Inc. | Inhibition or reversal of skin aging by actin-sequestering peptides |
US6855806B1 (en) | 1999-10-15 | 2005-02-15 | Curagen Corporation | Thymosin beta 10-like proteins and nucleic acids encoding same |
US6992170B2 (en) | 1999-10-15 | 2006-01-31 | Curagen Corporation | Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin |
DE10030149A1 (de) * | 2000-06-20 | 2002-01-10 | Switch Biotech Ag | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen oder Wundheilung sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen |
EP1176200A3 (de) | 2000-06-20 | 2005-01-12 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen |
FR2814076B1 (fr) * | 2000-09-21 | 2002-12-20 | Centre Nat Rech Scient | Agent angiogenique et ses utilisations |
US8652546B2 (en) | 2007-09-06 | 2014-02-18 | Tahitian Noni International, Inc. | Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals |
US7244463B2 (en) * | 2005-10-18 | 2007-07-17 | Tahitian Noni International, Inc. | Garcinia mangostana L. enhanced animal food product |
US20110217394A1 (en) * | 2000-12-05 | 2011-09-08 | Brett Justin West | Iridoid Based Formulations |
US6855345B2 (en) * | 2001-11-02 | 2005-02-15 | Morinda, Inc. | Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions |
US20040192761A1 (en) * | 2003-03-25 | 2004-09-30 | Palu Afa Kehaati | Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor |
US8790727B2 (en) * | 2000-12-05 | 2014-07-29 | Tahitian Noni International, Inc. | Morinda citrifolia and iridoid based formulations |
US20070196527A1 (en) * | 2006-02-23 | 2007-08-23 | Jensen Claude J | Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions |
US8574642B2 (en) | 2000-12-05 | 2013-11-05 | Tahitian Noni International, Inc. | Antiviral Morinda citrifolia L. based formulations and methods of administration |
US20110171333A1 (en) * | 2000-12-05 | 2011-07-14 | Bryant Wadsworth | Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products |
AU2002255736B2 (en) * | 2001-03-15 | 2006-08-31 | Regenerx, Biopharmaceuticals, Inc. | Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (Tbeta4), analogues, isoforms and other derivatives |
AU2006233251B2 (en) * | 2001-03-15 | 2008-10-02 | Regenerx Biopharmaceuticals, Inc. | Methods for Treating Disorders of the Eye and Surrounding Tissue with Thymosin Beta4 (TBeta4), Analogues, Isoforms and Other Derivatives |
WO2002083159A1 (en) * | 2001-04-17 | 2002-10-24 | Morinda, Inc. | Palliative effects of morinda citrifolia oil and juice |
CN101549148A (zh) * | 2001-08-29 | 2009-10-07 | 雷根内克斯生物制药有限公司 | 多肽在制备用于促进心内膜细胞向间质细胞转化的药物中的应用 |
US7070813B2 (en) * | 2001-11-02 | 2006-07-04 | Morinda, Inc. | Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor |
US7442395B2 (en) * | 2002-11-14 | 2008-10-28 | Tahitian Noni International, Inc. | Formulation for treating candidiasis using Morinda citrifolia |
US20110160057A1 (en) * | 2001-11-14 | 2011-06-30 | Bryant Wadsworth | Morinda Citrifolia Based Antimicrobial Formulations |
GB0130608D0 (en) | 2001-12-21 | 2002-02-06 | Psimedica Ltd | Medical fibres and fabrics |
TWI353849B (en) * | 2002-01-25 | 2011-12-11 | Us Gov Health & Human Serv | Methods and compositions for the promotion of hair |
US7202066B2 (en) * | 2002-01-29 | 2007-04-10 | Carrington Laboratories, Inc. | Combination of a growth factor and a protease enzyme |
AU2008201749B2 (en) * | 2002-02-06 | 2010-05-13 | Regenerx Biopharmaceuticals, Inc. | Treatment of Infections and Other Disorders |
EP2266595A3 (de) * | 2002-02-06 | 2011-07-06 | Regenerx Biopharmaceuticals, Inc. | Behandlung von Infektionen und anderen Erkrankungen |
US20060264360A1 (en) * | 2002-04-12 | 2006-11-23 | Yale University Office Of Cooperstive Research | Anti-inflammatory and wound healing effects of lymphoid thymosin beta-4 |
US6821524B2 (en) * | 2002-06-03 | 2004-11-23 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions |
EP1613369A4 (de) * | 2003-03-31 | 2008-10-01 | Regenerx Biopharmaceuticals | Zusammensetzungen und verfahren zur abgabe von thymosin beta 4, analoga, isoformen und anderer derivate |
US20060269630A1 (en) * | 2003-04-16 | 2006-11-30 | Palu Afa K | Morinda citrifolia as a 5-Lipoxygenase inhibitor |
JP4073826B2 (ja) * | 2003-06-04 | 2008-04-09 | タヒチアン ノニ インターナショナル インコーポレーテッド | ヤエヤマアオキの抽出物を含む農業用活力剤 |
KR20060063898A (ko) * | 2003-07-18 | 2006-06-12 | 리지너크스 바이오 파마소티컬스, 인코포레이티드 | 방사선 노출에 기인한 손상의 치료 또는 예방 |
US20070259060A1 (en) * | 2003-08-12 | 2007-11-08 | Mian-Ying Wang | Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane |
CN1897965A (zh) * | 2003-12-22 | 2007-01-17 | 雷金纳克斯生物制药公司 | 反应性的化学剂、生物剂或毒素引起的生物反应或免疫反应的治疗方法或预防方法 |
JP2007537153A (ja) * | 2004-03-05 | 2007-12-20 | リジェナークス・バイオファーマスーティカルズ・インコーポレイテッド | 細胞外基質蓄積の治療または防止 |
JP2008510732A (ja) * | 2004-08-20 | 2008-04-10 | ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム | 心臓組織の損傷を処置、予防、阻害、または緩和する方法 |
WO2006023879A1 (en) | 2004-08-20 | 2006-03-02 | Board Of Regents, The University Of Texas System | Screening of agents for activity against ischemic myocardial insults |
US8716215B2 (en) | 2005-01-13 | 2014-05-06 | Regenerx Biopharmaceuticals, Inc. | Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease |
US20060204601A1 (en) * | 2005-03-09 | 2006-09-14 | Palu Afa K | Formulations and methods for preventing and treating substance abuse and addiction |
US20060280818A1 (en) * | 2005-05-26 | 2006-12-14 | Palu Afa K | Nicotinic acetylcholine receptor antagonist |
US20070122507A1 (en) * | 2005-05-26 | 2007-05-31 | Palu Afa K | Histone deacetylase and tumor necrosis factor converting enzyme inhibition |
KR20080033939A (ko) * | 2005-06-17 | 2008-04-17 | 리지너크스 바이오 파마소티컬스, 인코포레이티드 | 동결 건조된 형태이거나, 또는 동결 건조될 수 있는 형태인엘케이케이티이티 및/또는 엘케이케이티엔티 펩티드조성물들 |
KR100984635B1 (ko) * | 2005-07-15 | 2010-10-01 | 주식회사 바이오톡스텍 | 티모신 β4 유도체 및 이의 용도 |
CN101232896B (zh) * | 2005-07-26 | 2013-04-24 | 雷金纳克斯生物制药公司 | 治疗或预防由充血性心力衰竭导致的组织恶化、组织损伤或损害的方法 |
US20070184137A1 (en) * | 2005-11-29 | 2007-08-09 | Palu Afa K | Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes |
US20070154579A1 (en) * | 2005-11-29 | 2007-07-05 | Palu Afa K | Morinda Citrifolia Based Formulation And Methods For Weight Management |
US20070166417A1 (en) * | 2005-11-29 | 2007-07-19 | Palu Afa K | Formulation and Methods for Use of Morinda Citrifolia Seed Oil |
WO2007070660A2 (en) | 2005-12-13 | 2007-06-21 | President And Fellows Of Harvard College | Scaffolds for cell transplantation |
JP2009523804A (ja) * | 2006-01-17 | 2009-06-25 | リジェナークス・バイオファーマスーティカルズ・インコーポレイテッド | 血流の増加によって引きおこされる組織損傷を処置または予防する方法 |
US20070281903A1 (en) * | 2006-05-04 | 2007-12-06 | Palu Afa K | Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX |
US8025910B2 (en) | 2006-05-12 | 2011-09-27 | Tahitian Noni International, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
US8535741B2 (en) | 2006-05-12 | 2013-09-17 | Morinda, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
AU2007288410A1 (en) * | 2006-08-18 | 2008-02-28 | Regenerx Biopharmaceuticals, Inc. | Methods and compositions for conserving and/or preparing an organ or tissue for transplant |
EP2076277A4 (de) * | 2006-10-06 | 2011-06-01 | Regenerx Biopharmaceuticals | Verfahren zur behandlung von gewebeverschleiss, -verletzungen oder -schäden aufgrund von erkrankungen des zahnfleischs oder der mundschleimhaut und/oder zur herunterregulierung von nf-kappab oder zur unterdrückung von durch nf-kappab vermittelter vorgängen |
KR20150072458A (ko) | 2006-11-15 | 2015-06-29 | 코다 테라퓨틱스, 인크. | 상처 치유를 위한 개선 방법 및 조성물 |
CA2621452A1 (en) * | 2007-02-21 | 2008-08-21 | Innovational Holdings, Llc | Stent and method for reducing tissue damage after ischemic injury with thymosin b4 |
US20080317890A1 (en) * | 2007-06-21 | 2008-12-25 | Claude Jarakae Jensen | Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical |
US9770535B2 (en) * | 2007-06-21 | 2017-09-26 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
CA2699026A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
WO2009033816A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of the combination of thymosin beta 10 and thymosin alpha 1 peptides as a therapeutic agent |
KR20100057050A (ko) * | 2007-09-11 | 2010-05-28 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 데슬로렐린 및 마스토파란의 용도 |
EP2234656A2 (de) | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Verbesserte medizinische vorrichtungen |
US20090196944A1 (en) * | 2008-02-01 | 2009-08-06 | Brad Rawson | Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS |
CN102006891B (zh) | 2008-02-13 | 2017-04-26 | 哈佛学院董事会 | 连续的细胞程序化装置 |
US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
US9012399B2 (en) | 2008-05-30 | 2015-04-21 | President And Fellows Of Harvard College | Controlled release of growth factors and signaling molecules for promoting angiogenesis |
CN101297965B (zh) * | 2008-06-16 | 2011-01-05 | 浙江省中医药研究院 | 胸腺肽β4在制备防治支气管哮喘药物中的应用 |
US8822647B2 (en) | 2008-08-26 | 2014-09-02 | City Of Hope | Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells |
JP2012522005A (ja) * | 2009-03-26 | 2012-09-20 | ヘンリー フォード ヘルス システム | 神経損傷および神経変性疾患後の神経学的転帰を改善する方法 |
WO2010120749A2 (en) | 2009-04-13 | 2010-10-21 | President And Fellow Of Harvard College | Harnessing cell dynamics to engineer materials |
US8230654B2 (en) | 2009-06-10 | 2012-07-31 | Comc, Llc | Medallion insert for modular flooring assemblies |
US8782989B2 (en) | 2009-06-11 | 2014-07-22 | Comc, Llc | Narrow lined modular flooring assemblies |
JP5926180B2 (ja) | 2009-07-31 | 2016-05-25 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 寛容原性療法のための細胞のプログラミングの方法 |
GB2476789A (en) * | 2009-11-10 | 2011-07-13 | Gl Holdings Inc Bv | Use of thymosin for treatment of type 2 diabetes |
US20110206786A1 (en) * | 2010-02-23 | 2011-08-25 | Brett Justin West | Acai and Iridoid Based Formulations |
EP2542230A4 (de) | 2010-03-05 | 2013-08-28 | Harvard College | Förderung des anwachsens von skelettmuskel-stammzellen durch gleichzeitige verabreichung von vegf und igf-1 |
KR101297037B1 (ko) * | 2010-03-26 | 2013-08-14 | 숙명여자대학교산학협력단 | 혈관신생촉진용 펩타이드 및 이의 용도 |
EP2585053A4 (de) | 2010-06-25 | 2014-02-26 | Harvard College | Gemeinsame freisetzung von stimulations- und hemmfaktoren zur erzeugung von temporär stabilen und räumlich begrenzten zonen |
WO2012044783A2 (en) * | 2010-09-30 | 2012-04-05 | Regenerx Biopharmaceuticals, Inc. | Method of achieving a thymosin beta 4 concentration in a human patient |
PT2624873T (pt) | 2010-10-06 | 2020-03-04 | Harvard College | Hidrogéis injectáveis formadores de poros para terapias celulares à base de materiais |
WO2012064697A2 (en) | 2010-11-08 | 2012-05-18 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
WO2012126047A1 (en) * | 2011-03-18 | 2012-09-27 | Adistem Ltd | Agent and method for treating pain and reducing inflammation |
WO2012148684A1 (en) | 2011-04-27 | 2012-11-01 | President And Fellows Of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
ES2878089T3 (es) | 2011-04-28 | 2021-11-18 | Harvard College | Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva |
US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
EP2714073B1 (de) | 2011-06-03 | 2021-03-10 | President and Fellows of Harvard College | Krebsimpfstoff zur in-situ-antigen-erzeugung |
US20130022687A1 (en) * | 2011-07-19 | 2013-01-24 | Fitzgerald Jr John James | Topical transdermal method for delivering nutrients through the skin for expedited wound healing |
US8632827B2 (en) * | 2011-12-13 | 2014-01-21 | Avon Products, Inc | Modulation of thymosin beta-4 in skin |
KR102060391B1 (ko) * | 2011-12-23 | 2019-12-30 | 헨리 포드 헬쓰 시스템 | 말초 신경병증의 회복을 증진시키기 위한 방법, 시스템, 및 조성물 |
ES2773895T3 (es) | 2012-04-16 | 2020-07-15 | Harvard College | Composiciones de sílice mesoporosa para modular las respuestas inmunitarias |
US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
US9808654B2 (en) | 2013-02-11 | 2017-11-07 | Jan Marini Skin Research | Post procedure skin care gel and methods of use thereof |
US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
DE102013017203A1 (de) * | 2013-10-16 | 2015-04-16 | Isa Atay | Thymustherapie |
EP3137105A4 (de) | 2014-04-30 | 2017-12-27 | President and Fellows of Harvard College | Kombinationsimpfstoffvorrichtungen und -verfahren zur abtötung von krebszellen |
EA201790434A1 (ru) | 2014-08-22 | 2017-07-31 | Окленд Юнисервисиз Лимитед | Модуляторы каналов |
KR101530278B1 (ko) * | 2014-09-04 | 2015-06-24 | 부산대학교 산학협력단 | 심근전환유전자 및 심혈관재생유전자를 포함하는 아데노부속바이러스를 유효성분으로 포함하는, 허혈성 심장질환 예방 또는 치료용 조성물 |
BR112017005631A2 (pt) | 2014-09-19 | 2018-06-26 | City Of Hope | células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2 |
EP3210614A4 (de) * | 2014-10-22 | 2018-06-13 | G-Treebnt Co., Ltd. | Zusammensetzung mit thymosin beta 4 und pharmazeutische formulierung damit |
AU2016205338A1 (en) * | 2015-01-06 | 2017-08-03 | Venturis Therapeutics, Inc. | Therapeutic angiogenesis for wound healing |
AU2016205336A1 (en) | 2015-01-06 | 2017-08-03 | Venturis Therapeutics, Inc. | Angiogenic treatment of ischemic heart disease |
EP3250250A4 (de) | 2015-01-30 | 2019-05-22 | President and Fellows of Harvard College | Peritumorale und intratumorale materialien zur krebstherapie |
EP3259012A4 (de) | 2015-02-16 | 2018-09-19 | CardioVascular BioTherapeutics, Inc. | Therapeutische angiogenese zur behandlung erektiler dysfunktionen |
CN107708756A (zh) | 2015-04-10 | 2018-02-16 | 哈佛学院院长等 | 免疫细胞捕获装置及其制备和使用方法 |
CN108026729B (zh) | 2015-09-10 | 2020-02-14 | Comc有限责任公司 | 模块化地板组件 |
US10744088B2 (en) | 2015-10-06 | 2020-08-18 | G-Treebnt Co., Ltd. | Method for preparing ophthalmic preparation containing thymosin beta-4 |
EP3411475A4 (de) | 2016-02-06 | 2019-09-11 | President and Fellows of Harvard College | Rekapitulation der hämatopoietischen nische zur wiederherstellung der immunität |
MX2018013546A (es) * | 2016-05-06 | 2019-04-22 | Phasebio Pharmaceuticals Inc | Proteinas de fusion de elp para liberacion controlada y sostenida. |
AU2017295704B2 (en) | 2016-07-13 | 2023-07-13 | President And Fellows Of Harvard College | Antigen-presenting cell-mimetic scaffolds and methods for making and using the same |
KR102340750B1 (ko) * | 2017-03-03 | 2021-12-21 | 에이치엘비테라퓨틱스 주식회사 | 티모신 베타 4를 유효성분으로 포함하는 안정화된 외용 제제 |
CN110585055B (zh) * | 2019-08-26 | 2023-06-13 | 武汉贝缇安卡医疗健康投资有限公司 | AcSDKP在增加成纤维细胞分泌Ⅲ型胶原蛋白含量的应用 |
CN111249534B (zh) * | 2020-01-16 | 2021-06-15 | 中国人民解放军总医院 | 可用于促进创面组织同步修复再生的生物活性支架及其制备方法 |
EP4132546A4 (de) * | 2020-04-07 | 2024-05-01 | Combangio Inc | Aus lyophilisierten mesenchymalen stammzellen abgeleitetes sekretom und verwendungen davon |
CN111888462B (zh) * | 2020-08-10 | 2022-08-26 | 中国人民解放军军事科学院军事医学研究院 | 胸腺素β4在制备微生态平衡调节剂中的应用 |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261982A (en) * | 1977-11-09 | 1981-04-14 | The Procter & Gamble Company | Therapeutic composition |
US4297276A (en) * | 1979-03-23 | 1981-10-27 | Hoffman-La Roche Inc. | Thymosin beta 3 and beta 4 |
US4444757A (en) * | 1981-11-16 | 1984-04-24 | Research Corporation | Use of thymosin as an anti-diabetes and anti-hypertensive disease agent |
US4389343A (en) * | 1981-12-24 | 1983-06-21 | Hoffmann-La Roche Inc. | Immunopotentiating peptides from thymus |
US4388234A (en) * | 1981-12-28 | 1983-06-14 | Hoffmann-La Roche Inc. | Peptide isolation |
FR2530466A1 (fr) | 1982-07-21 | 1984-01-27 | Hecmati Michel | Gel anti-ride, produit et procede |
WO1984002274A1 (en) | 1982-12-09 | 1984-06-21 | Hafsten Raymond J Jr | Activated, stabilized enzymes useful for wound healing |
WO1984003437A1 (en) | 1983-03-01 | 1984-09-13 | Rudolf Trensch | Method and product for the treatment or hair |
US4543340A (en) * | 1983-04-07 | 1985-09-24 | George Washington University | Radioimmunoassay of thymosin β4 |
GB8330969D0 (en) * | 1983-11-21 | 1983-12-29 | Wellcome Found | Promoting healing |
JPS60142908A (ja) | 1983-12-29 | 1985-07-29 | Kanebo Ltd | 養毛化粧料 |
GB8517402D0 (en) * | 1985-07-10 | 1985-08-14 | Wellcome Found | Treatment of viral infections |
US4713394A (en) * | 1986-01-17 | 1987-12-15 | Thornfeldt Carl R | Treatment of nonacne inflammatory and infectious dermatoses and hair loss |
JPS62252711A (ja) | 1986-04-24 | 1987-11-04 | Hideharu Tamaki | 養毛剤 |
US4983581A (en) * | 1988-05-20 | 1991-01-08 | Institute Of Molecular Biology, Inc. | Wound healing composition of IGF-I and TGF-β |
US5055447A (en) * | 1988-07-28 | 1991-10-08 | Genentech, Inc. | Method and compositions for the treatment and prevention of septic shock |
JPH02101019A (ja) * | 1988-10-05 | 1990-04-12 | Genichiro Soma | 抗エイズ剤 |
JPH02142717A (ja) | 1988-11-22 | 1990-05-31 | Kanebo Ltd | 養毛化粧料 |
US5654267A (en) * | 1988-12-20 | 1997-08-05 | La Jolla Cancer Research Center | Cooperative combinations of ligands contained within a matrix |
EP0410348A1 (de) | 1989-07-26 | 1991-01-30 | G.D. Searle & Co. | Topische Spironolakton-Zusammensetzung |
US5068315A (en) | 1990-04-12 | 1991-11-26 | University Of Dundee | Composition for the regulation of hair growth |
GB9014221D0 (en) | 1990-06-26 | 1990-08-15 | Janssen Pharmaceutica Nv | Method of treating alopecia |
JPH04234325A (ja) * | 1990-12-27 | 1992-08-24 | Hoechst Japan Ltd | 脳および神経障害治療予防剤 |
CN1173991C (zh) * | 1992-11-13 | 2004-11-03 | 马克斯普朗克科学促进协会 | 作为血管内皮生长因子受体的f1k-1 |
US6124259A (en) * | 1993-01-28 | 2000-09-26 | Celtrix Pharmaceuticals, Inc. | Method for treating ophthalmic disorders with IGFBP |
AU6204594A (en) * | 1993-02-22 | 1994-09-14 | Ulrich-Christoph Von Arnim | Use of heparins for the treatment of inflammatory or immunological diseases |
AU6771594A (en) * | 1993-04-22 | 1994-11-08 | George Washington University, The | Method of decreasing the toxicity of therapeutic compositions using thymosin beta 4 |
US5358703A (en) * | 1993-09-27 | 1994-10-25 | Mcw Research Foundation, Inc. | Method for the detection of nitric oxide |
US5593964A (en) * | 1993-10-07 | 1997-01-14 | The George Washington University Medical Center | Method of treating septic shock by preventing actin polymerization |
WO1995009646A1 (en) * | 1993-10-07 | 1995-04-13 | The George Washington University Medical Center | METHOD OF TREATING SEPTIC SHOCK USING THYMOSIN β¿4? |
US5578570A (en) * | 1993-10-07 | 1996-11-26 | The George Washington University Medical Center | Method of treating septic shock using thymosin β4 |
FR2711060B1 (fr) * | 1993-10-13 | 1995-11-17 | Oreal | Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet. |
US5591716A (en) * | 1993-11-19 | 1997-01-07 | New York University | Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins |
CA2139385C (en) * | 1994-02-04 | 2001-12-25 | Gottfried Alber | Products containing g-csf and tnf binding protein |
US5652209A (en) * | 1994-04-29 | 1997-07-29 | University Of Miami | Use of secretory products of human lacrimal gland acinar epithelia for tear replacement therapy |
FR2719481B1 (fr) | 1994-05-05 | 1996-05-31 | Oreal | Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux. |
JPH07316022A (ja) | 1994-05-24 | 1995-12-05 | Kyowa Hakko Kogyo Co Ltd | 育毛剤 |
JP3202135B2 (ja) | 1994-08-10 | 2001-08-27 | カネボウ株式会社 | 頭髪化粧料 |
DE19509354A1 (de) * | 1994-12-08 | 1996-06-13 | Klett Loch Lore M | Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall |
FR2741076B1 (fr) | 1995-11-15 | 1998-01-30 | Rech De Pathologie Appliquee S | Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant |
DE19622422A1 (de) * | 1996-06-04 | 1997-12-11 | Sanorell Pharma Gmbh & Co | Lagerungsstabile pharmazeutische Zusammensetzung mit immun - modulierenden und antiinflammatorischen Eigenschaften sowie ein Verfahren zu dessen Herstellung |
US5663071A (en) * | 1996-06-17 | 1997-09-02 | Children's Medical Center Corporation | Human thymosin β 15 gene, protein and uses thereof |
JP3128203B2 (ja) * | 1997-02-10 | 2001-01-29 | 一男 坪田 | 分泌腺細胞とリンパ球との接着阻害剤 |
DE19711939A1 (de) * | 1997-03-21 | 1998-09-24 | Bosch Gmbh Robert | Vorrichtung zur Erfassung des Drucks und der Temperatur im Saugrohr einer Brennkraftmaschine |
DE19731420A1 (de) * | 1997-07-22 | 1999-01-28 | Bosch Gmbh Robert | Vorrichtung zur Erfassung des Drucks und der Temperatur im Saugrohr einer Brennkraftmaschine und Verfahren zu ihrer Herstellung |
US6030948A (en) * | 1997-12-19 | 2000-02-29 | Mann; Morris A. | Hair regeneration compositions for treatment of alopecia and methods of application related thereto |
GB9806632D0 (en) | 1998-03-28 | 1998-05-27 | Stevenson Robert | Peptide factor |
US20040067227A1 (en) * | 2001-11-02 | 2004-04-08 | Goldstein Allan L. | Inhibition or reversal of skin aging by actin-sequestering peptides |
WO2002036143A1 (en) | 2000-11-02 | 2002-05-10 | Regenerx Biopharmaceuticals, Inc. | Inhibition or reversal of skin aging by actin-sequestering peptides |
CA2338928A1 (en) | 1998-07-30 | 2000-02-10 | Hynda K. Kleinman | Thymosin .beta.4 promotes wound repair |
US6586403B1 (en) * | 2000-07-20 | 2003-07-01 | Salpep Biotechnology, Inc. | Treating allergic reactions and inflammatory responses with tri-and dipeptides |
US7560280B2 (en) * | 2000-11-03 | 2009-07-14 | Kourion Therapeutics Gmbh | Human cord blood derived unrestricted somatic stem cells (USSC) |
US6821524B2 (en) * | 2002-06-03 | 2004-11-23 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions |
JP3870918B2 (ja) * | 2002-10-23 | 2007-01-24 | 株式会社デンソー | 温度センサ一体型圧力センサ装置 |
RU2295963C1 (ru) | 2005-10-18 | 2007-03-27 | Закрытое акционерное общество Научно-производственное предприятие "Тринита" | Способ получения иммуностимулятора |
-
1999
- 1999-07-29 CA CA002338928A patent/CA2338928A1/en not_active Abandoned
- 1999-07-29 EP EP10186120A patent/EP2311485A1/de not_active Withdrawn
- 1999-07-29 ES ES99937654T patent/ES2239846T5/es not_active Expired - Lifetime
- 1999-07-29 EP EP04078459A patent/EP1591128A1/de not_active Withdrawn
- 1999-07-29 WO PCT/US1999/017282 patent/WO2000006190A1/en active IP Right Grant
- 1999-07-29 MX MXPA01001041A patent/MXPA01001041A/es active IP Right Grant
- 1999-07-29 EP EP99937654A patent/EP1100529B2/de not_active Expired - Lifetime
- 1999-07-29 DE DE69924615T patent/DE69924615T3/de not_active Expired - Lifetime
- 1999-07-29 PT PT99937654T patent/PT1100529E/pt unknown
- 1999-07-29 DK DK99937654.4T patent/DK1100529T4/da active
- 1999-07-29 AT AT99937654T patent/ATE292473T1/de active
- 1999-07-29 AU AU52443/99A patent/AU766826B2/en not_active Ceased
-
2001
- 2001-01-29 US US09/772,445 patent/US20070111931A9/en not_active Abandoned
- 2001-11-23 HK HK01108257A patent/HK1038307A1/xx not_active IP Right Cessation
-
2004
- 2004-05-26 US US10/853,505 patent/US7268118B2/en not_active Expired - Fee Related
-
2005
- 2005-11-22 US US11/284,430 patent/US8143218B2/en not_active Expired - Fee Related
-
2007
- 2007-03-09 US US11/715,997 patent/US20090023663A1/en not_active Abandoned
-
2010
- 2010-11-02 US US12/938,228 patent/US20110124550A1/en not_active Abandoned
-
2017
- 2017-05-12 US US15/594,045 patent/US20170326207A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070111931A9 (en) | 2007-05-17 |
DE69924615T3 (de) | 2011-05-05 |
EP1100529B1 (de) | 2005-04-06 |
MXPA01001041A (es) | 2002-06-04 |
US8143218B2 (en) | 2012-03-27 |
CA2338928A1 (en) | 2000-02-10 |
EP1100529A1 (de) | 2001-05-23 |
ES2239846T5 (es) | 2011-03-04 |
DK1100529T3 (da) | 2005-12-19 |
HK1038307A1 (en) | 2002-03-15 |
ES2239846T3 (es) | 2005-10-01 |
US20070009469A1 (en) | 2007-01-11 |
US20090023663A1 (en) | 2009-01-22 |
WO2000006190A1 (en) | 2000-02-10 |
DE69924615T2 (de) | 2006-02-02 |
US20040220111A1 (en) | 2004-11-04 |
ATE292473T1 (de) | 2005-04-15 |
US20030060405A1 (en) | 2003-03-27 |
EP1100529B2 (de) | 2010-08-25 |
PT1100529E (pt) | 2005-10-31 |
AU5244399A (en) | 2000-02-21 |
US20170326207A1 (en) | 2017-11-16 |
AU766826B2 (en) | 2003-10-23 |
US7268118B2 (en) | 2007-09-11 |
EP1591128A1 (de) | 2005-11-02 |
US20110124550A1 (en) | 2011-05-26 |
EP2311485A1 (de) | 2011-04-20 |
DK1100529T4 (da) | 2010-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69924615D1 (de) | Thymosin beta 4 stimuliert wundheilung | |
DE69839529D1 (de) | Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen | |
ATE84420T1 (de) | Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen. | |
DE69827001D1 (de) | Gewebedezellularization | |
DE69728057D1 (de) | Iontophoretische auslösbare lieferungsvorrichtung zur verminderung von elektrischen empfindungen | |
NO963742L (no) | Fremgangsmåte til å stimulere hematopoese med hemaglobin | |
DE3781263T2 (de) | Peptid-derivate und deren verwendung in der therapie. | |
ATE252639T1 (de) | Modifizierter, das dorsalgewebe beeinflussender faktor | |
IT1232827B (it) | Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle | |
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
ATE239498T1 (de) | Entzündungshemmende zusammensetzung | |
DE3578611D1 (de) | Instrumente zur behandlung von verformten naegeln bei menschlichen patienten. | |
ATE294236T1 (de) | Promotor der tie rezeptor protein kinase | |
NO920125D0 (no) | Fremgangsmaate for aa bestemme den funksjonelle aktivitetentil fri protein s eller protein c i en plasma-proeve | |
ATE239225T1 (de) | Injektion durch elektromigration von einer mikroreservoir elektrode in ein kapillares separationssystem | |
DK403384A (da) | Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf | |
DE69015175D1 (de) | Glykoprotein-hormonrezeptor-moleküle. | |
NO873437L (no) | Human placenta angiogen faktor i stand til aa stimulere kapillaer endotelcelle-proteasesyntese, dna-syntese og migrasjon. | |
SE9803962L (sv) | Nukleinsyra som kodar för natriumtunnel i nervvävnad | |
DE69825307D1 (de) | Verwendung von protein h als zytostattischer wirkstoff | |
DE295827T1 (de) | Verwendung von 24,25-dihydroxycholecalciferol bei der heilung von knochenbruechen. | |
IT1286182B1 (it) | Impiego della relaxina o relassina, come nuovo agente farmacologico antistaminico per bloccare il rilascio di istamina nei tessuti in | |
DK467286D0 (da) | Protese til implantation i knoglevaev | |
MX9710291A (es) | Inhibidores ligantes de proteinas de fijacion con factor de crecimiento del tipo de insulina y metodos de uso para los mismos. | |
ATE79636T1 (de) | Peptid-derivate und deren verwendung in der therapie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: KLUNKER, SCHMITT-NILSON, HIRSCH, 80797 MUENCHEN |
|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings |